(Q46931047)

26 December 2017

title

New medical treatments in Cushing disease (English)

1 reference

26 December 2017

author

Thierry Brue

series ordinal

2

1 reference

26 December 2017

author name string

L Bricaire

series ordinal

1

1 reference

26 December 2017

language of work or name

French

0 references

publication date

1 June 2007

1 reference

26 December 2017

published in

Annales d'Endocrinologie

1 reference

26 December 2017

volume

68 Suppl 1

1 reference

26 December 2017

page(s)

18-20

1 reference

26 December 2017

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

The Effects of SOM230 on Cell Proliferation and Adrenocorticotropin Secretion in Human Corticotroph Pituitary Adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

Retinoic acid as a novel medical therapy for Cushing's disease in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

Retinoic acid prevents experimental Cushing syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

Dopamine receptor expression and function in corticotroph pituitary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

Octreotide exerts different effects in vivo and in vitro in Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2807%2980005-9

10.1016/S0003-4266(07)80005-9

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017